Using Viruses as Vectors

May 20, 2020

Sigma Xi member and virologist Ann Skalka explains how some approaches to developing a vaccine for SARS-CoV-2 involve using other viruses to safely teach our bodies to recognize the new coronavirus. Skalka, professor emerita at Fox Chase Cancer Center, talks with science communicator Brian Malow (@sciencecomedian) for our video series that connects COVID-19 questions with scientists.

See more from our video interview series in the COVID-19 Preparedness Kit

More About Sigma Xi: Sigma Xi, The Scientific Research Honor Society is the world’s largest multidisciplinary honor society for scientists and engineers. Its mission is to enhance the health of the research enterprise, foster integrity in science and engineering, and promote the public understanding of science for the purpose of improving the human condition. Sigma Xi chapters can be found at colleges and universities, government laboratories, and industry research centers around the world. More than 200 Nobel Prize winners have been members. The Society is based in Research Triangle Park, North Carolina. On Twitter: @SigmaXiSociety